The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Grifols Australia Pty Ltd
Regulatory activities for this sponsor.
Loading...
Sponsor content
7 result(s) found, displaying 1 to 7
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Grifols Australia Pty Ltd - Reagent red blood cell IVDs.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Grifols Australia Pty Ltd - Immunohaematology sensitised cell-typing IVDs.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Grifols Australia Pty Ltd - Procleix Parvo HAV - Hepatitis A/Parvovirus B19 virus nucleic acid IVD, kit, nucleic acid technique (NAT).
-
INTRATECT 5% 1g in 20 mL human normal immunoglobulin solution for intravenous infusion vial (164550)
ARTGAustralian Register of Therapeutic Goods (ARTG) information for INTRATECT 5% 1g in 20 mL human normal immunoglobulin solution for intravenous infusion vial. -
ARTGAustralian Register of Therapeutic Goods (ARTG) information for INTRATECT 5% 10g in 200 mL human normal immunoglobulin solution for intravenous infusion vial.
-
INTRATECT 5% 5g in 100mL human normal immunoglobulin solution for intravenous infusion vial (164551)
ARTGAustralian Register of Therapeutic Goods (ARTG) information for INTRATECT 5% 5g in 100mL human normal immunoglobulin solution for intravenous infusion vial. -
ARTGAustralian Register of Therapeutic Goods (ARTG) information for INTRATECT 5% 2.5g in 50mL human normal immunoglobulin solution for intravenous infusion vial.